GH Research PLC Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for GHRS, updated each market day.
GHRS AI Sentiment
AI sees no strong directional signal for GH Research PLC Ordinary Shares stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About GH Research PLC Ordinary Shares
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Exchange
Market Cap
$947,188,861
Cap Tier
Employees
56
Listed Since
June 25, 2021
Website
GHRS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
GHRS Volatility
GH Research PLC Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
